09 July 2025
09 July 2025
In a more challenging regulatory environment for clinical trials, optimising trial designs early makes success more likely.
This is their third partnership, following earlier research collaborations involving J-Brain Cargo tech.
Chugai will make an initial payment to Gero, with potential additional payments up to $250m based on milestone achievements.
Research to be unveiled at IAS 2025 shows funding cuts are already influencing HIV prevalence.
This approval follows previous authorisations in the US, Israel and Australia.
The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
